Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market
more
Stories about Oligosaccharide
- Stories in:
-
Content:
All
- Date:
- Date:
Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market
moreBrenntag Food & Nutrition and Vitalus Nutrition sign new agreement in North America
moreUS Customs rules in favor of Jennewein Biotechnologie regarding importation of 2'-Fucosyllactose
moreJennewein Biotechnologie GmbH announces the foundation of Jennewein Biotech Corp. USA
moreJennewein publishes new results on the norovirus-inhibiting effect of complex oligosaccharides
moreSupply of Key Ingredient in advanced infant formula by Jennewein is secured
moreJennewein Biotechnologie GmbH enforces its patents in the field of human milk oligosaccharides against Nestlé in Germany
morePublication of a toxicological study: a milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-mix
moreJennewein Biotechnologie obtains US-FDA GRAS status on alternative 2'-fucosyllactose fermentation strain
moreJennewein Biotechnologie sues Glycom for patent infringement in Denmark
moreAdministrative Law Judge issues ruling in patent dispute concerning 2'-FL production and beta-galactosidase activity
moreJennewein Biotechnologie and Yili Group join forces in China for microbiome research and human milk oligosaccharides to bring innovation to the largest baby food market
moreJennewein Biotechnologie GmbH acquires Arthus Mineralsprings Bad Hönningen to build a new integrated fermentation and recovery plant for human milk oligosaccharides
moreEIB provides funding to Jennewein
moreJennewein Biotechnologie to build new R&D centre for synthetic organisms and microbiome research in Bonn, Germany
more
1